Brian Dill is currently the Director of Proteomics at BPGbio Inc., where they build strategies to characterize the E2/TPD platform through global proteomics profiling and chemical proteomics. Previously, they served as Principal Scientist in the Mass Spectrometry-based Proteomics group at EMD Serono, Inc., and held various leadership roles in Discovery Pharmacology. Brian's academic background includes a Ph.D. in Biomedical Science from East Tennessee State University and notable postdoctoral work at institutions such as the University of Dundee and Oak Ridge National Laboratory. They also contributed as a Senior Scientist at Merck and as a Research Support Specialist at Rockefeller University.
This person is not in any teams
This person is not in any offices